___

Hear­ing Aids Linked to Low­er Risk of Demen­tia, Depres­sion and Falls, Study Finds (Michi­gan Health Lab):

“Old­er adults who get a hear­ing aid for a new­ly diag­nosed hear­ing loss have a low­er risk of being diag­nosed with demen­tia, depres­sion or anx­i­ety in the fol­low­ing three years, and a low­er risk of suf­fer­ing fall-relat­ed injuries, than those who leave their hear­ing loss uncor­rect­ed, a new study finds. Read the rest of this entry »

___

An impaired sense of smell can sig­nal cog­ni­tive decline, but ‘smell train­ing’ could help (The Con­ver­sa­tion):

“As we age, we often have prob­lems with our abil­i­ty to smell (called olfac­to­ry dys­func­tion). Old­er peo­ple might not be able to iden­ti­fy an odour or dif­fer­en­ti­ate one odour from anoth­er. In some cas­es they might not be able to detect an odour at all.

Odour iden­ti­fi­ca­tion dif­fi­cul­ties are com­mon in peo­ple with neu­rode­gen­er­a­tive dis­eases, includ­ing Alzheimer’s dis­ease Read the rest of this entry »

___

Why tech­nol­o­gy — not med­ica­tion — is the future of treat­ing old­er adults with depres­sion (McK­night’s Long-term Care News):

“The go-to treat­ment for many cas­es of depres­sion is med­ica­tion.

Unfor­tu­nate­ly, this treat­ment option can cause as many issues as the prob­lem it is try­ing to solve. Anti­de­pres­sants can put res­i­dents at greater risk of falls, neg­a­tive health com­pli­ca­tions and oth­er poor con­di­tions. Some stud­ies indi­cate that anti­de­pres­sants may not be effec­tive for most old­er Amer­i­cans. Read the rest of this entry »

_______

Heads-up: The Alzheimer’s Research & Pre­ven­tion Foun­da­tion (ARPF), a long­stand­ing sup­port­er of Sharp­Brains events and activ­i­ties, will be con­duct­ing its first Brain Longevi­ty Ther­a­py Train­ing — com­bin­ing pro­fes­sion­al devel­op­ment with a cer­ti­fi­ca­tion process — next week in Los Ange­les, CA (also with a livestream option).

And they are gen­er­ous­ly shar­ing dis­count codes (below) for inter­est­ed Sharp­Brains read­ers. Read the rest of this entry »

_______

The Alzheimer’s Research & Pre­ven­tion Foun­da­tion (ARPF), a long­stand­ing sup­port­er of Sharp­Brains events and activ­i­ties, will be con­duct­ing its first Brain Longevi­ty Ther­a­py Train­ing — com­bin­ing pro­fes­sion­al devel­op­ment with a cer­ti­fi­ca­tion process — dur­ing 4 days late Octo­ber in Los Ange­les, CA (also with a livestream option). And they are gen­er­ous­ly shar­ing dis­count codes for inter­est­ed Sharp­Brains read­ers (see below) Read the rest of this entry »